Victrex (VCT) H1 2025 earnings summary

Executive summary

• H1 2025 sales volumes rose 16% year-over-year to 2,018 tonnes, with strong growth in VARs (+30%), electronics (+17%), and energy/industrial (+15%), while transport declined 2% and medical was flat.

• Revenue increased 5% to £145.9m (8% in constant currency), but gross profit declined 4% to £64.3m due to mix, FX, and China ramp-up costs; ASP fell 10%.

• Underlying PBT was £23.2m, down 17% year-over-year but flat in constant currency; reported PBT was £17.2m, up due to lower exceptional items.

• Strong cash conversion at 128%, with operating cash flow of £30.7m–£34.6m and free cash flow of £22.5m; net debt reduced to £40.7m.

• Interim dividend maintained at 13.42p per share, reflecting confidence in future cash flows.

Financial highlights

• Gross margin fell 390bps to 44.1%, mainly due to China plant ramp-up costs, FX, and sales mix; excluding China, gross margin would have been 46.6%.

• Overheads rose 5% to £40.3m, mainly from wage inflation and employee rewards.

• CapEx was materially lower at £8.6m (vs £21.8m prior year), with capex guidance at 8–10% of revenue.

• Net debt at £40.7m, improved from £49.8m in H1 2024; inventory down £12.3m to £114.4m.

• Underlying EPS dropped 16% to 22.6p; reported EPS up 461% to 17.4p.

Outlook and guidance

• Upgraded full-year volume growth guidance to high single digits, from mid-single digits.

• ASP guidance for FY25 lowered to £72–75/kg, reflecting mix shift toward lower-priced segments.

• Gross margin guidance for FY25 now 45–47%, below original guidance due to mix and China costs.

• Targeting substantial H2 underlying PBT growth vs H1, with full-year PBT similar to prior year in constant currency.

• Capex at lower end of 8–10% of revenue; continued strong cashflow expected.